Literature DB >> 28199191

Trans-synaptic homeostasis at the myasthenic neuromuscular junction.

Jaap J Plomp1.   

Abstract

Properly sustained impulse transmission at the neuromuscular junction (NMJ) is crucial for successful muscle contraction. To guarantee this, NMJs not only possess a considerable safety factor in transmission but also have the ability to adjust the presynaptic acetylcholine release level to cope with any changes in the postsynaptic neurotransmitter sensitivity. This review will provide overview on the discovery and characterization of this synaptic homeostatic mechanism, especially in the condition of the neuromuscular disorder myasthenia gravis (MG) where the postsynaptic transmitter sensitivity at the NMJ becomes severely reduced due to autoimmune attack of acetylcholine receptors. Because homeostatic signalling and adaptation is presumably maximally active in this condition, NMJs from MG animal models are important study objects. Although candidate post- and presynaptic factors as well as the retrograde signals have been proposed, the homeostatic mechanism at the MG NMJ is still incompletely understood. Further identification and functional characterization of key factors is important because these may form new therapeutic targets in MG.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28199191     DOI: 10.2741/4532

Source DB:  PubMed          Journal:  Front Biosci (Landmark Ed)        ISSN: 2768-6698


  9 in total

1.  Salbutamol modifies the neuromuscular junction in a mouse model of ColQ myasthenic syndrome.

Authors:  Grace M McMacken; Sally Spendiff; Roger G Whittaker; Emily O'Connor; Rachel M Howarth; Veronika Boczonadi; Rita Horvath; Clarke R Slater; Hanns Lochmüller
Journal:  Hum Mol Genet       Date:  2019-07-15       Impact factor: 6.150

Review 2.  Post-synaptic specialization of the neuromuscular junction: junctional folds formation, function, and disorders.

Authors:  Suqi Zou; Bing-Xing Pan
Journal:  Cell Biosci       Date:  2022-06-19       Impact factor: 9.584

Review 3.  Homeostatic synaptic plasticity at the neuromuscular junction in myasthenia gravis.

Authors:  Xueyong Wang; Mark M Rich
Journal:  Ann N Y Acad Sci       Date:  2017-10-05       Impact factor: 5.691

Review 4.  Congenital Myasthenic Syndromes or Inherited Disorders of Neuromuscular Transmission: Recent Discoveries and Open Questions.

Authors:  Sophie Nicole; Yoshiteru Azuma; Stéphanie Bauché; Bruno Eymard; Hanns Lochmüller; Clarke Slater
Journal:  J Neuromuscul Dis       Date:  2017

Review 5.  The Structure of Human Neuromuscular Junctions: Some Unanswered Molecular Questions.

Authors:  Clarke R Slater
Journal:  Int J Mol Sci       Date:  2017-10-19       Impact factor: 5.923

Review 6.  The Muscle Is Not a Passive Target in Myasthenia Gravis.

Authors:  Jean-Thomas Vilquin; Alexandra Clarissa Bayer; Rozen Le Panse; Sonia Berrih-Aknin
Journal:  Front Neurol       Date:  2019-12-19       Impact factor: 4.003

7.  Effects of 3,4-diaminopyridine on myasthenia gravis: Preliminary results of an open-label study.

Authors:  Marco Ceccanti; Laura Libonati; Gabriele Ruffolo; Pierangelo Cifelli; Federica Moret; Vittorio Frasca; Eleonora Palma; Maurizio Inghilleri; Chiara Cambieri
Journal:  Front Pharmacol       Date:  2022-08-16       Impact factor: 5.988

Review 8.  Animal Models of the Neuromuscular Junction, Vitally Informative for Understanding Function and the Molecular Mechanisms of Congenital Myasthenic Syndromes.

Authors:  Richard G Webster
Journal:  Int J Mol Sci       Date:  2018-04-29       Impact factor: 5.923

9.  Myasthenia Gravis: From the Viewpoint of Pathogenicity Focusing on Acetylcholine Receptor Clustering, Trans-Synaptic Homeostasis and Synaptic Stability.

Authors:  Masaharu Takamori
Journal:  Front Mol Neurosci       Date:  2020-05-28       Impact factor: 5.639

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.